"Ärztliche Leitung: Dr. med. Thomas Dietze, PD Dr. med. Christoph Jensen FESC, FSCMR Über uns: Das B. Braun Ambulante Herzzentrum Kassel mit seinen sechs Kardiologischen Zweigpraxen (Borken, Baunatal, Frankenberg, Fritzlar, Melsungen, Witzenhausen) gehört seit 2019 zum B. Braun-Verbund. Das B. Braun Ambulante Herzzentrum Kassel befindet sich in unmittelbarer Nähe zu den DRK-Kliniken Nordhessen. Auf einer Fläche von 1.700 Quadratmetern verteilen sich großzügige Aufenthaltsbereiche, zehn Behandlungsräume, acht Sprechzimmer, sieben Zweibettzimmer sowie zwei Eingriffsräume. Die hochmoderne technische Ausstattung der Praxis ermöglicht das komplette Spektrum der Diagnostik und Therapie."

During the past decade, Ambulantes Herzzentrum Kassel conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ambulantes Herzzentrum Kassel" #1 sponsor was "Amgen" with 3 trials, followed by "ResMed" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 1 trials sponsored and "Leipzig Heart Institute GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ambulantes Herzzentrum Kassel" #1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ambulantes Herzzentrum Kassel" are "Heart Failure" (2 trials), "Sleep Disordered Breathing" (2 trials), "Atherosclerotic Cardiovascular Disease" (1 trials), "Chronic Heart Failure" (1 trials) and "Congestive Heart Failure" (1 trials). Many other conditions were trialed in "Ambulantes Herzzentrum Kassel" in a lesser frequency.

Most popular intervention types in "Ambulantes Herzzentrum Kassel" are "Drug" (4 trials), "Device" (2 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Evolocumab" (2 trials), "Placebo" (2 trials), "Bempedoic acid and/or its fixed-dose combination with ezetimibe" (1 trials), "CRT-D implantation" (1 trials) and "CRT-P implantation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ambulantes Herzzentrum Kassel" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Ambulantes Herzzentrum Kassel". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ambulantes Herzzentrum Kassel, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Ambulantes Herzzentrum Kassel, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".